98%
921
2 minutes
20
Herpes simplex virus (HSV) and cytomegalovirus (CMV) are DNA viruses that are common among humans. Severely immunocompromised patients are at increased risk of developing HSV or CMV disease due to a weakened immune system. Antiviral therapy can be challenging because these drugs have a narrow therapeutic window and show significant pharmacokinetic variability. Above that, immunocompromised patients have various comorbidities like impaired renal function and are exposed to polypharmacy. This scoping review discusses the current pharmacokinetic (PK) and pharmacodynamic (PD) knowledge of antiviral drugs for HSV and CMV treatment in immunocompromised patients. HSV and CMV treatment guidelines are discussed, and multiple treatment interventions are proposed: early detection of drug resistance; optimization of dose to target concentration by therapeutic drug monitoring (TDM) of nucleoside analogs; the introduction of new antiviral drugs; alternation between compounds with different toxicity profiles; and combinations of synergistic antiviral drugs. This research will also serve as guidance for future research, which should focus on prospective evaluation of the benefit of each of these interventions in randomized controlled trials.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863155 | PMC |
http://dx.doi.org/10.3390/pharmaceutics15010163 | DOI Listing |
Microorganisms
August 2025
Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Periodontal diseases in pediatric subjects represent a challenging and relatively underexplored area compared to the extensive data available about periodontal diseases in adults. The present narrative review aims to explore the periodontal status and the related subgingival and/or salivary microbial profiles in pediatric subjects (≤18 years), focusing also on the state of health or systemic diseases. In healthy periodontium, early colonizers, such as and spp.
View Article and Find Full Text PDFBMC Infect Dis
August 2025
Department of Virology, University of Helsinki, PO Box 21, 00014, Helsinki, Finland.
Background: Beyond herpes simplex virus (HSV), the pathogenic role and occurrence of other human herpesviruses (HHVs) in the genitourinary tract remain largely unclear. This study aimed to determine the prevalence and level of shedding of nine typical human-infecting herpesviruses in genitourinary specimens of young women.
Methods: We investigated the prevalence and quantity of HHVs using qPCR in urogenital samples from 380 women participating in a community-randomized human papillomavirus (HPV) vaccination trial and in a randomized trial on the effectiveness of Chlamydia trachomatis screening.
Soc Sci Med
July 2025
Robert N. Butler Columbia Aging Center, Columbia University, United States; Department of Epidemiology, Mailman School of Public Health, Columbia University, United States.
Background: Socioeconomic status (SES) disadvantage shapes exposure to persistent infections and immune aging, but its life-course effects remain understudied. Early adulthood is a crucial period, as immune aging may begin before clinical signs appear.
Methods: Data from the National Longitudinal Study of Adolescent to Adult Health (Add Health) were used to assess SES disadvantage across adolescence (Wave I) and young adulthood (Wave IV).
Ann Behav Med
January 2025
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States.
Background: Adolescence is a critical period when youth develop their decision-making skills and may engage in their first sexual encounters. Stress during this time can affect decision making; however, limited research has examined the relationship between biological stress correlates and sexual behavior among adolescent girls and young women (AGYW) in high-HIV incidence areas.
Purpose: To examine whether stress-responsive biomarkers are longitudinally associated with sexual behaviors that are predictive of HIV.
Int J Mol Sci
August 2025
Department of Psychiatry, "Carol Davila" University of Medicine and Pharmacy Bucharest, 020021 Bucharest, Romania.
Schizophrenia is a challenging multifactorial neuropsychiatric disease that involves interactions between genetic susceptibility and environmental insults. Increasing evidence implicates viral infections as significant environmental contributors, particularly during sensitive neurodevelopmental periods. This review synthesises current findings on the viral hypothesis of schizophrenia, encompassing a wide array of neurotropic viruses, including influenza viruses, herpesviruses (HSV-1 and 2, CMV, VZV, EBV, HHV-6 and 8), hepatitis B and C viruses, HIV, HERVs, HTLV, Zika virus, BoDV, coronaviruses (including SARS-CoV-2), and others.
View Article and Find Full Text PDF